Literature DB >> 12091281

Oxygen therapy for infants with chronic lung disease.

S Kotecha1, J Allen.   

Abstract

Supplemental oxygen is a safe and effective treatment for infants with established chronic lung disease who are not at risk of further progression of retinopathy of prematurity (ROP). Oxygen saturations of < 92% should be avoided and a target range of at least 94-96% aimed for. The saturation target range for very preterm infants at risk of developing ROP is more controversial, but the therapeutic index is probably considerably narrower.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12091281      PMCID: PMC1721438          DOI: 10.1136/fn.87.1.f11

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  36 in total

1.  Home oxygen promotes weight gain in infants with bronchopulmonary dysplasia.

Authors:  J R Groothuis; A A Rosenberg
Journal:  Am J Dis Child       Date:  1987-09

2.  Cost of preventing retrolental fibroplasia?

Authors:  K W Cross
Journal:  Lancet       Date:  1973-10-27       Impact factor: 79.321

3.  Effect of oxygen on right ventricular performance evaluated by radionuclide angiography in two young patients with chronic lung disease.

Authors:  B E Alpert; M A Gainey; D V Schidlow; M A Capitanio
Journal:  Pediatr Pulmonol       Date:  1987 May-Jun

Review 4.  Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants.

Authors:  L M Askie; D J Henderson-Smart
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 5.  Early versus late discontinuation of oxygen in preterm or low birth weight infants.

Authors:  L M Askie; D J Henderson-Smart
Journal:  Cochrane Database Syst Rev       Date:  2000

6.  Experience with home oxygen in the management of infants with bronchopulmonary dysplasia.

Authors:  S H Abman; F J Accurso; B L Koops
Journal:  Clin Pediatr (Phila)       Date:  1984-09       Impact factor: 1.168

7.  Pulmonary vascular response to oxygen in infants with severe bronchopulmonary dysplasia.

Authors:  S H Abman; R R Wolfe; F J Accurso; B L Koops; C M Bowman; J W Wiggins
Journal:  Pediatrics       Date:  1985-01       Impact factor: 7.124

8.  Sending infants home on low-flow oxygen.

Authors:  M Groeneveld
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  1986 May-Jun

9.  Pulse oximetry in very low birth weight infants with acute and chronic lung disease.

Authors:  R Ramanathan; M Durand; C Larrazabal
Journal:  Pediatrics       Date:  1987-04       Impact factor: 7.124

10.  Pulse oximetry for continuous oxygen monitoring in sick newborn infants.

Authors:  M Durand; R Ramanathan
Journal:  J Pediatr       Date:  1986-12       Impact factor: 4.406

View more
  6 in total

Review 1.  Home oxygen for children: who, how and when?

Authors:  I M Balfour-Lynn; R A Primhak; B N J Shaw
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

2.  Polysomnography in preterm infants and children with chronic lung disease.

Authors:  Sharon A McGrath-Morrow; Timothy Ryan; Brian M McGinley; Sande O Okelo; Laura M Sterni; J Michael Collaco
Journal:  Pediatr Pulmonol       Date:  2011-08-03

3.  Looking beyond PPHN: the unmet challenge of chronic progressive pulmonary hypertension in the newborn.

Authors:  Candice D Fike; Judy L Aschner
Journal:  Pulm Circ       Date:  2013-11-19       Impact factor: 3.017

4.  Are preterm-born survivors at risk of long-term respiratory disease?

Authors:  Katarzyna Kaczmarczyk; Ida Wiszomirska; Magdalena Szturmowicz; Andrzej Magiera; Michalina Błażkiewicz
Journal:  Ther Adv Respir Dis       Date:  2017-07       Impact factor: 4.031

5.  Impact of a protocol-driven unified service for neonates with bronchopulmonary dysplasia.

Authors:  Natalie Batey; Dushyant Batra; Jon Dorling; Jayesh Mahendra Bhatt
Journal:  ERJ Open Res       Date:  2019-03-25

6.  Management of Prematurity-Associated Wheeze and Its Association with Atopy.

Authors:  Martin O Edwards; Sarah J Kotecha; John Lowe; Louise Richards; W John Watkins; Sailesh Kotecha
Journal:  PLoS One       Date:  2016-05-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.